TP53 and head and neck squamous cell carcinoma: Our prior studies showed that HNSCC patients with PIK3CA amplification (PIK3CAAmp) exhibited a higher frequency of harboring TP53 mutations (TP53Mutated) compared with patients with WT PIK3CA [22].